KLRS
#4137
Kalaris Therapeutics, Inc. - Common Stock
2.2 6 USD
-0.04%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-4.24%
Changement Mensuel
-33.72%
Evolution sur 6 mois
-64.07%
Changement Annuel
-77.91%
Clôture Précédente
2.3 6
Open
2.3 7
Low
2.2 2
High
2.3 7
Financials
2022
Current report, Q3 FY2022
Kalaris Therapeutics, Inc. current report, Q3 FY2022
8-K
Current report, Q3 FY2022
Kalaris Therapeutics, Inc. current report, Q3 FY2022
8-K
Quarterly report, Q2 FY2022
Kalaris Therapeutics, Inc. quarterly report, Q2 FY2022
10-Q
Current report, Q2 FY2022
Kalaris Therapeutics, Inc. current report, Q2 FY2022
8-K
Current report, Q2 FY2022
Kalaris Therapeutics, Inc. current report, Q2 FY2022
8-K
Quarterly report, Q1 FY2022
Kalaris Therapeutics, Inc. quarterly report, Q1 FY2022
10-Q
Current report, Q1 FY2022
Kalaris Therapeutics, Inc. current report, Q1 FY2022
8-K
Current report, Q1 FY2022
Kalaris Therapeutics, Inc. current report, Q1 FY2022
8-K
Current report, Q1 FY2022
Kalaris Therapeutics, Inc. current report, Q1 FY2022
8-K
2021
Annual report, FY2021
Kalaris Therapeutics, Inc. annual report, FY2021
10-K